This page in English

Virginija Danylaité Karrenbauer

Anknuten

Besöksadress : Widerströmska Huset Tomtebodavägen 18a, 5 Tr 171 77 Stockholm
Postadress : Institutionen för klinisk neurovetenskap (CNS), K8, Neuro Hillert, Widerströmska Huset Tomtebodavägen 18a, 5 Tr 171 77 Stockholm

Publikationer

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
Freedman Ms, Bar-or A, Oger J, Traboulsee A, Patry D, Young C, et al
Neurology 2011;77(16):1551-60

Plasma cerebrosterol measures predict cognitive processing speed deterioration 7 years later in MS patients
Stawiarz L, Bergendal G, Almkvist O, Fredrikson S, Link J, Leoni V, et al
MULTIPLE SCLEROSIS JOURNAL 2012;:496-497

MS disease related variables and its impact on gray matter volume and cortical thickness
Karrenbauer Vd
JOURNAL OF NEUROIMMUNOLOGY 2012;253(1-2):19-19

Monogenetic Multiple Sclerosis or Spastic Paraplegia with Inflammation in a Consanguineous Family?
Imrell K, Karrenbauer V, Bomfim Il, Roshanisefat H, Lamb B, Hillert J, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2012;76(2):207-207

Interferon-Beta Therapy-Induced Elevation of Serum IL-7 Levels is Blocked by Anti-Drug Antibodies
Hermanrud C, Lundstrom W, Karrenbauer V, Hillert J, Fogdell-hahn A
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2012;76(2):200-201

Interferon-beta therapy-induced elevation of serum IL-7 levels is blocked by anti-drug antibodies
Hermanrud C, Lundstrom W, Karrenbauer V, Hillert J, Fogdell-hahn A
JOURNAL OF NEUROIMMUNOLOGY 2012;253(1-2):69-70

Impact of OCB status and HLA-DRB1 risk alleles on lesion load in MS patients at age 40
Karrenbauer V, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K
EUROPEAN JOURNAL OF NEUROLOGY 2012;:352-352

Cross-sectional study on relationship between Symbol Digit Modalities Test, plasma cerebrosterol concentration and MRI-based brain volumes of MS patients
Bergendal G, Stawiarz L, Almkvist O, Fredrikson S, Glaser A, Hillert J, et al
EUROPEAN JOURNAL OF NEUROLOGY 2012;:711-711

Elevated Plasma IL-7 Levels in Multiple Sclerosis Patients Treated with Interferon Beta are Caused by Decreased Cell Consumption
Hermanrud C, Lundstrom W, Sjostrand M, Brauner S, Wahren-herlenius M, Olsson T, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2013;77(4):316-316

Cerebrosterol levels in serum: does it reflect axonal damage in CNS?
Novakova L, Malmestrom C, Axelsson M, Masterman T, Bjorkhem I, Hillert J, et al
MULTIPLE SCLEROSIS JOURNAL 2013;19(11):299-299

Number of OCBs in CSF at diagnosis timepoint,- predictor of long term radiological outcome in MS?
Karrenbauer Vd, Evertsson B, Stawiarz L, Imrell K, Voevodskayac O, Wahlund Lo, et al
JOURNAL OF NEUROIMMUNOLOGY 2014;275(1-2):16-17

Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis
Novakova L, Axelsson M, Malmeström C, Zetterberg H, Björkhem I, Karrenbauer Vd, et al
Journal of the neurological sciences 2015;358(1-2):201-6

Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls
Granberg T, Hashim F, Andersen O, Sundal C, Karrenbauer Vd
European journal of neurology 2016;23(4):817-22

Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis
Thangarajh M, Masterman T, Rot U, Duvefelt K, Brynedal B, Karrenbauer Vd, et al
JOURNAL OF NEUROIMMUNOLOGY 2005;167(1-2):210-4

Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis
Karrenbauer Vd, Leoni V, Lim Et, Giovannoni G, Ingle Gt, Sastre-garriga J, et al
CLINICAL NEUROLOGY AND NEUROSURGERY 2006;108(5):456-60

Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis
Liu Gz, Gomes Ac, Putheti P, Karrenbauer V, Kostulas K, Press R, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2006;64(4):412-9

Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [C-11]vinpocetine and [C-11]PK11195 in patients
Vas A, Shchukin Y, Karrenbauer Vd, Cselenyi Z, Kostulas K, Hillert J, et al
JOURNAL OF THE NEUROLOGICAL SCIENCES 2008;264(1-2):9-17

Comparison of MRI lesion location in multiple sclerosis patients with and without oligoclonal bands in the cerebrospinal fluid
Karrenbauer Vd, Prejs R, Imrell K, Glaser A, Masterman T, Hillert J
JOURNAL OF NEUROLOGY 2011;:154-155

Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients
Karrenbauer Vd, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K
Journal of neuroimmunology 2013;254(1-2):170-3

Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis
Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, et al
European journal of neurology 2015;22(2):328-33

Interferon beta treatment of multiple sclerosis increases serum interleukin-7
Lundström W, Hermanrud C, Sjöstrand M, Brauner S, Wahren-herlenius M, Olsson T, et al
Multiple sclerosis (Houndmills, Basingstoke, England) 2014;20(13):1727-36

Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy
Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund Lo, et al
Journal of neuroimmunology 2014;274(1-2):149-54

Visa alla publikationer